Cardiovascular Disease: Mouse Models of Atherosclerosis

The Mouse in Biomedical Research

Volumn 3, Issue , 2007, Pages 535-563

  Maeda, Nobuyo ^a   Givens, Raymond C ^b   Reddick, Robert L ^c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84863468362     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369454-6/50070-4     Document Type: Chapter

References (243)

1. Aalto-Setala K., Laitinen K., Erkkila L., Leinonen M., Jauhiainen M., Ehnholm C., et al. Chlamydia pneumoniae does not increase athero-sclerosis in the aortic root of apolipoprotein E-deficient mice. Arterioscler Thromb Vase Biol 2001, 21:578-584.
2. Actams M.R., Golden D.L., Register T.C., Anthony M.S., Hodgin J.B., Maeda N., Williams J.K. The atheroprotective effect of dietary soy isoflavones in apolipoprotein E-/-mice requires the presence of estrogen receptor-alpha. Arterioscler Thromb Vase Biol 2002, 22:1859-1864.
3. Actams M.R., Kaplan J.R., Manuck S.B., Koritnik D.R., Parks J.S., Wolfe M.S., Clarkson T.B. Inhibition of coronary artery atheroscle-rosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone. Arteriosclerosis 1990, 10:1051-1057.
4. Actan Y., Shibata K., Ni W, Tsuda Y., Sato M., Ikeda I., Imaizumi K. Concentration of serum lipids and aortic lesion size in female and male apo E-deficient mice fed docosahexaenoic acid. Biosci Biotechnol Biochem 1999, 63:309-313.
5. Aiello R.J., Bourassa P.A., Lindsey S., Weng W, Natoli E., Rollins B.J., Milos P.M. Monocyte chemoattractant protein-1 accelerates athero-sclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vase Biol 1999, 19:1518-1525.
6. Aiello R.J., Brees D., Bourassa P.A., Royer L., Lindsey S., Coskran T., et al. Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages. Arterioscler Thromb Vase Biol 2002, 22:630-637.
7. Alexander M.R., Knowles J.W, Nishikimi T., Maeda N. Increased ather-osclerosis and smooth muscle cell hypertrophy in natriuretic peptide receptor A-/-apolipoprotein E-/-mice. Arterioscler Thromb Vase Biol 2003, 23:1077-1082.
8. Allayee H., Ghazalpour A., Lusis A.J. Using mice to dissect genetic factors in atherosclerosis. Arterioscler Thromb Vase Biol 2003, 23:1501-1509.
9. American Heart Association Heart disease and stroke statistics: 2004 update 2003, Dallas, Texas.
10. Anderson J.L., Muhlestein J.B. Antibiotic trials for coronary heart disease. Tex Heart Inst J 2004, 31:33-38.
11. Ascherio A., Rimm E.B., Hernan M.A., Giovannucci E., Kawachi I., Stamper M.J., et al. Relation of consumption of vitamin E, vitamin C and carotenoids to risk for stroke among men in the United States. Ann Intern Med 1999, 130:963-970.
12. Barry-Lane P.A., Patterson C., van der Merwe M., Hu Z., Holland S.M., Yeh E.T., Runge M.S. p47phox is required for atherosclerotic lesion progression in ApoE (-/-) mice. J Clin Invest 2001, 108:1513-1522.
13. Black T.M., Wang P., Maeda N., Coleman R.A. Palm tocotrienols protect ApoE +/-mice from diet-induced atheroma formation. J Nutr 2000, 130:2420-2426.
14. Blanc J., Alves-Guerra M.C., Esposito B., Rousset S., Gourdy P., Ricquier D., et al. Protective role of uncoupling protein 2 in atherosclerosis. Circulation 2003, 107:388-390.
15. Bockamp E., Markiger M., Spangenberg C., Fees S., Fraser S., Eshkind L., et al. Of mice and models: improved animal models for biomedical research. Physiol Genomics 2002, 11:115-132.
16. Boisvert W.A., Santiago R., Curtiss L.K., Terkeltaub R.A. A leuko-cyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J Clin Invest 1998, 101:353-363.
17. Boring L., Gosling J., Cleary M., Charo I.F. Decreased lesion forma-tion in CCR2-/-mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998, 394:894-897.
18. Boucher P., Gotthardt M., Li W.P., Anderson R.G., Herz J. LRP: role in vascular wall integrity and protection from atherosclerosis. Science 2003, 300:329-332.
19. Bourassa P.A., Milos P.M., Gaynor B.J., Breslow J.L., Aiello RJ. Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficientmice. ProcNatlAcadSci USA 1996, 93:10022-10027.
20. Braun A., Trigatti B.L., Post M.J., Sato K., Simons M., Edelberg J.M., et al. Loss of SR-BI expression leads to the early onset of occlusive ather-osclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice. Circ Res 2002, 90:270-276.
21. Braun A., Zhang S., Miettinen H.E., Ebrahim S., Holm T.M., Vasile E., et al. Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouse. Proc Natl Acad Sci. USA 2003, 100:7283-7288.
22. Brennan M.L., Anderson M.M., Shih D.M., Qu X.D., Wang X., Mehta A.C., et al. Increased atherosclerosis in myeloperoxidase-deficient mice. J. Clin Invest 2001, 107:419-430.
23. Brewer H.B., Sprecher D.L., Gregg R.E., Hoeg J.M. Risk factors for the development of premature cardiovascular disease. Adv Exp Med Biol 1985, 183:27-36.
24. Buono C., Come C.E., Witztum J.L., Maguire G.F., Connelly P.W., Carroll M., Lichtman A.H. Influence of C3 deficiency on atherosclerosis. Circulation 2002, 105:3025-3031.
25. Burleigh M.E., Babaev V.R., Oates J.A., Harris R.C., Gautam S., Riendeau D., et al. Cyclooxygenase-2 promotes early atherosclerotic lesion forma-tion in LDL receptor-deficient mice. Circulation 2002, 105:1816-1823.
26. Butz G.M., Davisson R.L. Long-term telemetric measurement of car-diovascular parameters in awake mice: a physiological genomics tool. Physiol Genomics 2001, 5:89-97.
27. Byington R.P., Furberg C.D., Herrington D.M., Herd J.A., Hunninghake D., Lowery M., et al. Effect of estrogen plus progestin on progression of carotid atherosclerosis in postmenopausal women with heart disease: HERS B-mode substudy. Arterioscler Thromb Vase Biol 2002, 22:1692-1697.
28. Calara F., Silvestre M., Casanada E, Yuan N., Napoli C., Palinski W. Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice. J. Pathol 2001, 195:257-263.
29. Caligiuri G., Levy B., Pernow J., Thoren P., Hansson G.K. Myocardial infarction mediated by endothelin receptor signaling in hyperc-holesterolemic mice. Proc Natl Acad Sci USA 1999, 96:6920-6924.
30. Caligiuri G., Rottenberg M., Nicoletti A., Wigzell H., Hansson G.K. Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice. Circulation 2001, 103:2834-2838.
31. Caligiuri G., Rudling M., Ollivier V., Jacob M.P., Michel J.B., Hansson G.K., Nicoletti A. Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Mol Med 2003, 9:10-17.
32. Callow M.J., Verstuyft J., Tangirala R., Palinski W., Rubin E.M. Atherogenesis in transgenic mice with human apolipoprotein B and lipopro-tein (a) . J. Clin Invest 1995, 96:1639-1646.
33. Carmeliet P., Moons L., Dewerchin M., Rosenberg S., Herbert J.M., Lupu F., Collen D. Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice. J. Cell Biol 1998, 140:233-245.
34. Campbell L.A., Blessing E., Rosenfeld M., Lin T., Kuo C. Mouse models of C. pneumoniae infection and atherosclerosis. J Infect Dis 2000, 181(Suppl3):S508-S513.
35. Caron K.M., James L.R., Kim H.S., Knowles J., Uhlir R., Mao L., et al. Cardiac hypertrophy and sudden death in mice with a genetically clamped renin transgene. Proc Natl Acad Sci U S 2004, A101:3106-3 111.
36. Cascieri M.A. The potential for novel anti-inflammatory therapies for coronary artery disease. Nat Rev Drug Discov 2002, 1:122-130.
37. Churchill G.A., Airey D.C., Allayee H., et al. The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nat Genet 2004, 36:1133-1137.
38. Chae C.U., Ridker P.M., Manson J.E. Postmenopausal hormone replacement therapy and cardiovascular disease. Thromb Haemost 1997, 78:770-780.
39. Chien K.R. Genes and physiology: molecular physiology in genetically engineered animals. J Clin Invest 1996, 97:901-909.
40. Chu G., Haghighi K., Kranias E.G. From mouse to man: understanding heart failure through genetically altered mouse models. J Card Fail 2002, 8:432-449.
41. Collins R.G., Velji R., Guevara N.V., Hicks M.J., Chan L., Beaudet A.L. P-Selectin or intercellular adhesion molecule (ICAM) -l deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. J Exp Med 2000, 191:189-194.
42. Combadiere C., Potteaux S., Gao J.L., Esposito B., Casanova S., Lee E.J., et al. Decreased atherosclerotic lesion formation in CX3CR1/ apolipoprotein E double knockout mice. Circulation 2003, 107:1009-1016.
43. Crawford R.S., Kirk E.A., Rosenfeld M.E., LeBoeuf R.C., Chait A. Dietary antioxidants inhibit development of fatty streak lesions in the LDL receptor-deficient mouse. Arterioscler Thromb Vase Biol 1998, 18:1506-1513.
44. Crook M.F., Akyurek L.M. Gene transfer strategies to inhibit neoin-tima formation. Trends Cardiovasc Med 2003, 13:102-106.
45. Cyrus T., Witztum J.L., Rader D.J., Tangirala R., Fazio S., Linton M.F., Funk C.D. Disruption of the 12/15-lipoxygena die;se gene diminishes atherosclerosis in apo E-deficient mice. J Clin Invest 1999, 103:1597-1604.
46. Cyrus T., Yao Y, Rokach J., Tang L.X., Pratico D. Vitamin E reduces progression of atherosclerosis in low-density lipoprotein receptor-deficient mice with established vascular lesions. Circulation 2003, 107:521-523.
47. D'Orleans-Juste P., Honore J.C., Carrier E., Labonte J. Cardiovascular diseases: new insights from knockout mice. Curr Opin Pharmacol 2003, 3:181-185.
48. Dansky H.M., Charlton S.A., Harper M.M., Smith J.D. T and B lym-phocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci USA 1997, 94:4642-44646.
49. Daugherty A., Cassis L.A. Mouse models of abdominal aortic aneurysms. Arterioscler Thromb Vase Biol 2004, 24:429-434.
50. Daugherty A., Manning M.W., Cassis L.A. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J. Clin Invest 2000, 105:1605-1612.
51. Daugherty A., Pure E., Delfel-Butteiger D., Chen S., Leferovich J., Roselaar S.E., Rader DJ. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/-mice. J. Clin Invest 1997, 100:1575-1580.
52. Davies M.J. A macro and micro view of coronary vascular insult in ische acute;mie heart disease. Circulation 1990, 82:38-46.
53. Davignon J., Gregg R.E., Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988, 8:1-21.
54. Dawson T.C., Kuziel W.A., Osahar T.A., Maeda N. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 1999, 143:205-211.
55. Deng G.G., Martin-McNulty B., Sukovich D.A., Freay A., Halks-Miller M., Thinnes T., et al. Urokinase-type plasminogen activator plays a crit-ical role in angiotensin II-induced abdominal aortic aneurysm. Circ Res 2003, 92:510-517.
56. Detmers P.A., Hernandez M., Mudgett J., Hassing H., Burton C., Mundt S., et al. Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice. J Immunol 2000, 165:3430-3435.
57. Diez-Juan A., Perez P., Aracil M., Sancho D., Bernad A., Sanchez-Madrid F., Andres V. Selective inactivation of p27(Kipl) in hematopoietic progenitor cells increases neointimal macrophage proliferation and accelerates atherosclerosis. Blood 2004, 103:158-161.
58. Dimayuga P., Zhu J., Oguchi S., Chyu K.Y., Xu X.O., Yano J., et al. Reconstituted HDL containing human apolipoprotein A-l reduces VCAM-1 expression and neointima formation following periadventitial cuff-induced carotid injury in apoE null mice. Biochem Biophys Res Commun 1999, 264:465-468.
59. Doetschman T., Gregg R.G., Maeda N., Hooper M.L., Melton D.W., Thompson S., Smithies O. Targetted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature 1987, 330:576-578.
60. Dong Z.M., Chapman S.M., Brown A.A., Frenette P.S., Hynes R.O., Wagner D.D. The combined role of P-and E-selectins in atheroscle-rosis. J Clin Invest 1998, 102:145-152.
61. D'Orleans-Juste P., Honore J.C., Carrier E., Labonte J. Cardiovascular diseases: new insights from knockout mice. Curr Opin Pharmacol 2003, 3:181-185.
62. Elhage R., Arnal J.F., Pieraggi M.T., Duverger N., Fievet C., Faye J.C., Bayard F. 17 Beta-estradiol prevents fatty streak formation in apolipoprotein E-deflcient mice. Arterioscler Thromb Vase Biol 1997, 17:2679-2684.
63. Elhage R., Clamens S., Besnard S., Mallat Z., Tedgui A., Arnal J., et al. Involvement of interleukin-6 in atherosclerosis but not in the preven-tion of fatty streak formation by 17beta-estradiol in apolipoprotein E-deficient mice. Atherosclerosis 2001, 156:315-320.
64. Elhage R., Clamens S., Reardon-Alulis C., Getz G.S., Fievet C., Maret A., et al. Loss of atheroprotective effect of estradiol in immunodeficient mice. Endocrinology 2000, 141:462-465.
65. Elhage R., Jawien J., Rudling M, Ljunggren H.G., Takeda K., Akira S., et al. Reduced atherosclerosis in interleukin-18 deficient apolipopro-tein E-knockout mice. Cardiovasc Res 2003, 59:234-240.
66. Ezzahiri R., Stassen F.R., Kurvers H.A., van Pul M.M., Kitslaar P.J., Bruggeman C.A. Chlamydia pneumoniae infection induces an unsta-ble atherosclerotic plaque phenotype in LDL-receptor, ApoE double knockout mice. Eur J Vase Endovasc Surg 2003, 26:88-95.
67. Fabricant C.G., Fabricant J., Litrenta M.M., Minick C.R. Virus-induced atherosclerosis. J Exp Med 1978, 148:335-340.
68. Fayad Z.A., Fallon J.T., Shinnar M., Wehrli S., Dansky H.M., Poon M., et al. Noninvasive In vivo high-resolution magnetic resonance imag-ing of atherosclerotic lesions in genetically engineered mice. Circulation 1998, 98:1541-1547.
69. Fazio S., Major A.S., Swift L.L., Gleaves L.A., Accad M., Linton M.F., Farese R.V.Jr. Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages. J Clin Invest 2001, 107:163-171.
70. Fazio S., Sanan D.A., Lee Y.L., Ji Z.S., Mahley R.W., Rail S.C.Jr. Susceptibility to diet-induced atherosclerosis in transgenic mice expressing a dysfunctional human apolipoprotein E (Arg 112,Cysl42). Arterioscler Thromb 1994, 14:1873-1879.
71. Febbraio M., Podrez E.A., Smith J.D., Hajjar D.P., Hazen S.L., Hoff H.F., et al. Targeted disruption of the class B scavenger receptor CD36 pro-tects against atherosclerotic lesion development in mice. J Clin Invest 2000, 105:1049-1056.
72. Feng B., Zhang D., Kuriakose G., Devlin C.M., Kockx M., Tabas I. Niemann-Pick C heterozygosity confers resistance to lesional necrosis and macrophage apoptosis in murine atherosclerosis. Proc Natl Acad Sci USA 2003, 100:10423-10428.
73. Fitzgerald S.M., Gan L., Wickman A., Bergstrom G. Cardiovascular and renal phenotyping of genetically modified mice: a challenge for tradi-tional physiology. Clin Exp Pharmacol Physiol 2003, 30:207-216.
74. Gairola C.G., Drawdy M.L., Block A.E., Daugherty A. Sidestream cigarette smoke accelerates atherogenesis in apolipoprotein E-/-mice. Atherosclerosis 2001, 156:49-55.
75. Girod W.G., Jones S.R, Sieber N., Aw T.Y., Lefer D.J. Effects of hypercholesterolemia on myocardial ischemia-reperfusion injury in LDL receptor-deficient mice. Arterioscler Thromb Vase Biol 1999, 19:2776-2781.
76. Gordon J.W., Ruddle F.H. Integration and stable germ line transmis-sion of genes injected into mouse pronuclei. Science 1981, 214:1244-1246.
77. Gotto A.M. Antioxidants, statins, and atherosclerosis. J Am Coll Cardiol 2003, 41:1205-1210.
78. Gregg R.E., Zech L.A., Schaefer E.J., Stark D., Wilson D., Brewer H.B.Jr. Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest 1986, 78:815-821.
79. Grenache D.G., Coleman T., Semenkovich C.F., Santoro S.A., Zutter M.M. Alpha2betal integrin and development of atherosclerosis in a mouse model: assessment of risk. Arterioscler Thromb Vase Biol 2003, 23:2104-2109.
80. Guevara N.V., Kim H.S., Antonova E.I., Chan L. The absence of p53accelerates atherosclerosis by increasing cell proliferation in vivo. Nat Med 1999, 5:335-339.
81. Gu L., Okada Y., Clinton S.K., Gerard C., Sukhova G.K., Libby P., Rollins B.J. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998, 2:275-281.
82. Gupta S., Pablo A.M., Jiang X., Wang N., Tall A.R., Schindler C IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J. Clin Invest 1997, 99:2752-2761.
83. Haarbo J., Leth-Espensen P., Stender S., Christiansen C Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. J Clin Invest 1991, 87:1274-1279.
84. Hansson G.K. Inflammation and immune response in atherosclerosis. Curr Atheroscler Rep 1999, 1:150-155.
85. Harja E., Bucciarelli L.G., Lu Y, Stern D.M., Zou Y.S., Schmidt A.M., Yan S.F. Early growth response-1 promotes atherogenesis: mice defi-cient in early growth response-1 and apolipoprotein E display decreased atherosclerosis and vascular inflammation. Cire Res 2004, 94:333-339.
86. Hasuwa H., Kaseda K., Einarsdottir T., Okabe M. Small interfering RNA and gene silencing in transgenic mice and rats. FEBS Lett 2002, 532:227-230.
87. Hayek T., Masucci-Magoulas L., Jiang X., Walsh A., Rubin E., Breslow J.L., Tall A.R. Decreased early atherosclerotic lesions in hypertriglyceri-demic mice expressing cholesteryl ester transfer protein transgene. J. Clin Invest 1995, 96:2071-2074.
88. Hayek T., Pavlotzky E., Hamoud S., Coleman R., Keidar S., Aviram M., Kaplan M. Tissue angiotensin-converting-enzyme (ACE) , deficiency leads to a reduction in oxidative stress and in atherosclerosis: studies in ACE-knockout mice type 2. Arterioscler Thromb Vase Biol 2003, 23:2090-2096.
89. Heinecke J.W. Oxidative stress: new approaches to diagnosis and prog-nosis in atherosclerosis. Am J Cardiol 2003, 91:12A-16A.
90. Hemdahl A.L., Falk E., Thoren P., Hansson G.K. Thrombin inhibitor reduces myocardial infarction in apoE-/-x LDLR-/-mice. Am J Physiol Heart Cire Physiol 2004, 287:H872-H877.
91. Herrington D.M., Reboussin D.M., Brosnihan K.B., Sharp P.C., Shumaker S.A., Snyder T.E., et al. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med 2000, 343:522-529.
92. Hodgin J.B., Knowles J.W, Kim H.S., Smithies O., Maeda N. Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice. J Clin Invest 2002, 109:541-548.
93. Hodgin J.B., Krege J.H., Reddick R.L., Korach K.S., Smithies O., Maeda N. Estrogen receptor alpha is a major mediator of 17beta-estradiol's atheroprotective effects on lesion size in Apoe-/-mice. J Clin Invest 2001, 107:333-340.
94. Hodis H.N., Mack W.J., Lobo R.A., Shoupe D., Sevanian A., Mahrer P.R., et al. Estrogen in the prevention of atherosclerosis: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2001, 135:939-953.
95. Holm P., Stender S., Andersen H.O., Hansen B.F., Nordestgaard B.G. Antiatherogenic effect of estrogen abolished by balloon catheter injury in cholesterol-clamped rabbits. Arterioscler Thromb Vase Biol 1997, 17:1504-1511.
96. Hsich E., Zhou Y.F., Paigen B., Johnson T.M., Burnett M.S., Epstein S.E. Cytomegalovirus infection increases development of atherosclerosis in apolipoprotein-E knockout mice. Atherosclerosis 2001, 156:23-28.
97. Hu H., Pierce G.N., Zhong G. The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to. Chlamydia pneumoniae. J Clin Invest 1999, 103:747-753.
98. Idel S., Dansky H.M., Breslow J.L. A20, a regulator of NFkappaB, maps to an atherosclerosis locus and differs between parental sensitive C57BL/6J and resistant FVB/N strains. Proc Natl Acad Sci. USA 2003, 100:14235-14240.
99. Ishibashi S., Brown M.S., Goldstein J.L., Gerard R.D., Hammer R.E., Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin Invest 1993, 92:883-893.
100. Ishibashi S., Goldstein J.L., Brown M.S., Herz J., Burns D.K. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J Clin Invest 1994, 93:1885-1893.
101. Ishimori N., Li R., Kelmenson P.M., Korstanje R., Walsh K.A., Churchill G.A., et al. Quantitative trait loci analysis for plasma HDL-cholesterol concentrations and atherosclerosis susceptibility between inbred mouse strains C57BL/6J and 129Sl/SvIm. J. Arterioscler Thromb Vase Biol 2004, 24:161-166.
102. Itskovich V.V., Choudhury R.R, Aguinaldo J.G., Fallon J.T., Omerhodzic S., Fisher E.A., Fayad Z.A. Characterization of aortic root atheroscle-rosis in ApoE knockout mice: high-resolution in vivo and ex vivo MRM with histological correlation. Magn Reson Med 2003, 49:381-385.
103. Johnson R.C., Chapman S.M., Dong Z.M., Ordovas J.M., Mayadas T.N., Herz J., et al. Absence of P-selectin delays fatty streak formation in mice. J Clin Invest 1997, 99:1037-1043.
104. Joyce C.W., Amar M.J., Lambert G., Vaisman B.L., Paigen B., Najib-Fruchart J., et al. The ATP binding cassette transporter Al (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice. Proc Natl Acad Sci U S A 2002, 99:407-412.
105. Kaneda Y., Morishita R., Dzau V.J. Prevention of restenosis by gene therapy. Ann NY Acad Sci 1997, 811:299-308.
106. Kaneda Y., Morishita R., Dzau V.J. Prevention of restenosis by gene therapy. Ann NY Acad Sci 1997, 811:208-210. discussion.
107. King V.L., Szilvassy S.J., Daugherty A. Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-/-mice. Arterioscler Thromb Vase Biol 2002, 22:456-461.
108. Kirii H., Niwa T, Yamada Y, Wada H., Saito K., Iwakura Y, et al. Lack of interleukin-lbeta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vase Biol 2003, 23:656-660.
109. Klipstein-Grobusch K., Geleijnse J.M., den Breeijen J.H., Boeing H., Hofman A., Grobbee D.E., Witteman J.C. Dietary antioxidants and risk of myocardial infarction in the elderly: the Rotterdam Study. Am J Clin Nutr 1999, 69:261-266.
110. Knouff C., Hinsdale M.E., Mezdour H., Altenburg M.K., Watanabe M., Quarfordt S.H., et al. Apo E structure determines VLDL clearance and atherosclerosis risk in mice. J Clin Invest 1999, 103:1579-1586.
111. Knouff C., Malloy S., Wilder J., Altenburg M.K., Maeda N. Doubling expression of the low density lipoprotein receptor by truncation of the 3/-untranslated region sequence ameliorates type III hyperlipoproteinemia in mice expressing the human apoe2 isoform. J Biol Chem 2001, 276:3856-3862.
112. Knowles J.W., Maeda N. Genetic modifiers of atherosclerosis in mice. Arterioscler Thromb Vase Biol 2000, 20:2336-2345.
113. Knowles J.W., Esposito G., Mao L., Hagaman J.R., Fox J.E., Smithies O., et al. pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice. J Clin Invest 2001, 107:975-984.
114. Knowles J.W., Reddick R.L., Jennette J.C., Shesely E.G., Smithies O., Maeda N. Enhanced atherosclerosis and kidney dysfunction in eNOS (-/-) Apoe (-/-) mice are ameliorated by enalapril treatment. J Clin Invest 2000, 105:451-458.
115. Kong D., Melo L.G., Mangi A.A., Zhang L., Lopez-Qasaca M., Perrella M.A., Liew C.C., et al. Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation 2004, 109:1769-1775.
116. Krege J.H., Hodgin J.B., Hagaman J.R., Smithies O. A noninvasive computerized tail-cuff system for measuring blood pressure in mice. Hypertension 1995, 25:1111-1115.
117. Krege J.H., Moyer J.S., Langenbach L.L., Peng L., Zhang S.H., Maeda N., et al. Angiotensin-converting enzyme gene and atherosclerosis. Arterioscler Thromb Vase Biol 1997, 17:1245-1250.
118. Kubo N., Boisvert W.A., Ballantyne C.M., Curtiss L.K. Leukocyte CD lib expression is not essential for the development of atherosclerosis in mice. JLipidRes 2000, 41:1060-1066.
119. Kuhel D.G., Zhu B., Witte D.P., Hui D.Y Distinction in genetic determinants for injury-induced neointimal hyperplasia and diet-induced ath-erosclerosis in inbred mice. Arterioscler Thromb Vase Biol 2002, 22:955-960.
120. Kuhlencordt P.J., Chen J., Han F., Astern J., Huang PL. Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice. Circulation 2001, 103:3099-3104.
121. Kuhlencordt P.J., Gyurko R., Han F., Scherrer-Crosbie M., Aretz T.H., Hajjar R., et al. Accelerated atherosclerosis, aortic aneurysm forma-tion, and ische acute;mie heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation 2001, 104:448-454.
122. Kumar A., Lindner V. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler Thromb Vase Biol 1997, 17:2238-2244.
123. Kuziel W.A., Dawson T.C., Quinones M., Garavito E., Chenaux G., Ahuja S.S., et al. CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice. Atherosclerosis 2003, 167:25-32.
124. Kwak B.R., Veillard N., Pelli G., Mulhaupt F, James R.W, Chanson M., Mach F. Reduced connexin43 expression inhibits atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice. Circulation 2003, 107:1033-1039.
125. Lalla E., Lamster LB., Hofmann M.A., Bucciarelli L., Jerud A.P., Tucker S., et al. Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arterioscler Thromb Vase Biol 2003, 23:1405-1411.
126. Lardenoye J.H., Delsing D.J., de Vries M.R., Deckers M.M., Princen H.M., Havekes L.M., et al. Accelerated atherosclerosis by placement of a perivascular cuff and a cholesterol-rich diet in ApoE*3Leiden transgenic mice. Circ Res 2000, 87:248-253.
127. Layne M.D., Patel A., Chen Y.H., Rebel V.l., Carvajal I.M., Pellacani A., et al. Role of macrophage-expressed adipocyte fatty acid binding protein in the development of accelerated atherosclerosis in hypercholesterolemic mice. FASEB 2001, J15:2733-2735.
128. Lemaitre V, O'Byrne T.K., Borczuk A.C., Okada Y, Tall A.R., D'Armiento J. ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosis. J Clin Invest 2001, 107:1227-1234.
129. Lemaitre V, Soloway P.D., D'Armiento J. Increased medial degrada-tion with pseudo-aneurysm formation in apolipoprotein E-knockout mice deficient in tissue inhibitor of metalloproteinases-1. Circulation 2003, 107:333-338.
130. Lesnik P., Haskeil C.A., Charo I.F. Decreased atherosclerosis in CX3CR1-/-mice reveals a role for fractalkine in atherogenesis. J Clin Invest 2003, 111:333-340.
131. Li L., Messas E., Batista E.L., Levine R.A., Amar S. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation 2002, 105:861-867.
132. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
133. Libby P., Schoenbeck U., Mach F., Selwyn A.P., Ganz P. Current concepts in cardiovascular pathology: the role of LDL cholesterol in plaque rupture and stabilization. Am J Med 1998, 104:14S-18S.
134. Lijnen H.R. Matrix metalloproteinases and cellular fibrinolytic activity. Biochemistry (Mose) 2002, 67:92-98.
135. Linton M.F., Fazio S. Macrophages, inflammation, and atherosclerosis. Int J Obes Relat Metab Disord 2003, 27(Suppl 3):35-40.
136. Liu L., Hu H., Ji H., Murdin A.D., Pierce G.N., Zhong G. Chlamydia pneumoniae infection significantly exacerbates aortic atheroscle-rosis in an LDLR-/-mouse model within six months. Mol Cell Biochem 2000, 215:123-128.
137. Lusis A.J. Genetic factors in cardiovascular disease: 10 questions. Trends Cardiovasc Med 2003, 13:309-316.
138. Lutgens E., Gorelik L., Daemen M.J., de Muinck E.D., Grewal I.S., Koteliansky V.E., Flavell R.A. Requirement for CD154 in the pro-gression of atherosclerosis. Nat Med 1999, 5:1313-1316.
139. Luttun A., Lupu F, Storkebaum E., Hoylaerts M.F., Moons L., Crawley J., et al. Lack of plasminogen activator inhibitor-1 promotes growth and abnormal matrix remodeling of advanced atherosclerotic plaques in apolipoprotein E-deficient mice. Arterioscler Thromb Vase Biol 2002, 22:499-505.
140. Maeda N., Hagihara H., Nakata Y, Hiller S., Wilder J., Reddick R. Aortic wall damage in mice unable to synthesize ascorbic acid. Proc Natl Acad Sci USA 2000, 97:841-846.
141. Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988, 240:622-630.
142. Makowski L., Boord J.B., Maeda K., Babaev V.R., Uysal K.T., Morgan M.A., et al. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med 2001, 7:699-705.
143. Malloy S.L, Altenburg M.K., Knouff C., Lanningham-Foster L., Parks J.S., Maeda N. Harmful effects of increased LDLR expression in mice with human APOE*4 but not APOE*3. Arterioscler Thromb Vase Biol 2004, 24:91-97.
144. Mamontova A., Seguret-Mace S., Esposito B., Chaniale C., Bouly M., Delhaye-Bouchaud N., et al. Severe atherosclerosis and hypoal-phalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalpha. Circulation 1998, 98:2738-2743.
145. Manka D.R., Gilson W., Sarembock L, Ley K., Berr S.S. Noninvasive in vivo magnetic resonance imaging of injury-induced neointima formation in the carotid artery of the apolipoprotein-E null mouse. J Magn Re son Imaging 2000, 12:790-794.
146. Manka D.R., Wiegman P., Din S., Sanders J.M., Green S.A., Gimple L.W., et al. Arterial injury increases expression of inflammatory adhesion molecules in the carotid arteries of apolipoprotein-E-deficient mice. J Vase Res 1999, 36:372-378.
147. Manning M.W., Cassis L.A., Daugherty A. Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. Arterioscler Thromb Vase Biol 2003, 23:483-488.
148. Marotti K.R., Castle C.K., Boyle T.P., Lin A.H., Murray R.W., Melchior G.W. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature 1993, 364:73-75.
149. Marsh M.M., Walker V.R., Curtiss L.K., Banka C.L. Protection against atherosclerosis by estrogen is independent of plasma cholesterol levels in LDL receptor-deficient mice. J. Lipid Res 1999, 40:893-900.
150. Matsui Y., Rittling S.R., Okamoto H., Inobe M., Jia N., Shimizu T., et al. Osteopontin deficiency attenuates atherosclerosis in female apolipoprotein E-deficient mice. Arterioscler Thromb Vase Biol 2003, 23:1029-1034.
151. Matsushima Y, Hayashi S., Tachibana M. Spontaneously hyperlipi-demic (SHL) . mice: Japanese wild mice with apolipoprotein E deficiency. Mamm Genome 1999, 10:352-357.
152. Mehrabian M., Allayee H., Wong J., Shi W, Wang X.P., Shaposhnik Z., et al. Identification of 5-lipoxygena die;se as a major gene contributing to atherosclerosis susceptibility in mice. Circ Res 2002, 91:120-126.
153. Meilhac O., Ramachandran S., Chiang K., Santanam N., Parthasarathy S. Role of arterial wall antioxidant defense in beneficial effects of exer-cise on atherosclerosis in mice. Arterioscler Thromb Vase Biol 2001, 21:1681-1688.
154. Mendelsohn M.E., Karas R.H. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999, 340:1801-1811.
155. Miller N.E. Coronary atherosclerosis and plasma lipoproteins: epi-demiology and pathophysiologic considerations. J Cardiovasc Pharmacol 1982, 4(Suppl 2):190-195.
156. Moazed T.C., Campbell L.A., Rosenfeld M.E., Grayston J.T., Kuo C.C. Chlamydia pneumoniae infection accelerates the progression of ath-erosclerosis in apolipoprotein E-deficient mice. J Infect Dis 1999, 180:238-241.
157. Moghadasian M.H., McManus B.M., Godin D.V., Rodrigues B., Fro die;hlich J.J. Proatherogenic and antiatherogenic effects of probucol and phytosterols in apolipoprotein E-deficient mice: possible mechanisms of action. Circulation 1999, 99:1733-1739.
158. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993, 329:2002-2012.
159. Morham S.G., Langenbach R., Loftin C.D., Tiano H.F., Vouloumanos N., Jennette J.C., et al. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 1995, 83:473-482.
160. Mori N., Horie Y, Gerritsen M.E., Granger D.N. Ischemia-reperfusion induced microvascular responses in LDL-receptor -/-mice. Am J Physiol 1999, 276:1647-1654.
161. Mosca L. Estrogen and atherosclerosis. J. Invest Med 1998, 46:381-386.
162. Munday J.S., Thompson K.G., James K.A., Manktelow B.W. Dietary antioxidants do not reduce fatty streak formation in the C57BL/6 mouse atherosclerosis model. Arterioscler Thromb Vase Biol 1998, 18:114-119.
163. Muntwyler J., Hennekens C.H., Manson J.E., Gaziano J.M. Vitamin supplement use in a low-risk population of U.S. male physicians and subse-quent cardiovascular mortality. Arch Intern Med 2002, 162:1472-1476.
164. Murai A., Miyahara T., Fujimoto N., Matsuda M., Kameyama M. Lp (a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis 1986, 59:199-204.
165. Nageh M.F., Sandberg E.T., Marotti K.R., Lin A.H., Melchior E.P., Bullard D.C., Beaudet A.L. Deficiency of inflammatory cell adhe-sion molecules protects against atherosclerosis in mice. Arterioscler Thromb Vase Biol 1997, 17:1517-1520.
166. Naghavi M., Wyde P., Litovsky S., Madjid M., Akhtar A., Naguib S., et al. Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice. Circulation 2003, 107:762-768.
167. Nakashima Y, Plump A.S., Raines E.W., Breslow J.L., Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 1994, 14:133-140.
168. Nakata Y, Maeda N. Vulnerable atherosclerotic plaque morphology in apolipoprotein E-deficient mice unable to make ascorbic acid. Circulation 2002, 105:1485-1490.
169. Nathan L., Shi W, Dinh H., Mukherjee T.K., Wang X., Lusis A.J., Chaudhuri G. Testosterone inhibits early atherogenesis by conver-sion to estradiol: critical role of aromatase. Proc Natl Acad Sci U S A 2001, 98:3589-3593.
170. Niu X.L., Yang X., Hoshiai K., Tanaka K., Sawamura S., Koga Y, Nakazawa H. Inducible nitric oxide synthase deficiency does not affect the susceptibility of mice to atherosclerosis but increases collagen content in lesions. Circulation 2001, 103:1115-1120.
171. O'Connor S., Taylor C., Campbell L.A., Epstein S., Libby P. Potential infectious etiologies of atherosclerosis: a multifactorial perspec-tive. Emerg Infec Dis 2001, 7:780-788.
172. Onozuka H., Fujii S., Mikami T., Yamada S., Ishimori N., Shimizu T., et al. In vivo echocardiographic detection of cardiovascular lesions in apolipoprotein E-knockout mice using a novel high-frequency high-speed echocardiography technique. Cire J 2002, 66:272-276.
173. Paigen B., Morrow A., Brandon C., Mitchell D., Holmes P. Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis 1985, 57:65-73.
174. Parthasarathy S., Steinberg D., Witztum J.L. The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis. Annu Rev Med 1992, 43:219-225.
175. Patel S., Thelander E.M., Hernandez M., Montenegro J., Hassing H., Burton C., et al. ApoE (-/-) mice develop atherosclerosis in the absence of complement component C5. Biochem Biophys Res Commun 2001, 286:164-170.
176. Phelan S.A., Beier D.R., Higgins D.C., Paigen B. Confirmation and high resolution mapping of an atherosclerosis susceptibility gene in mice on Chromosome 1. Mamm Genome 2002, 13:548-553.
177. Piedrahita J.A., Zhang S.H., Hagaman J.R., Oliver P.M., Maeda N. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci U S A 1992, 89:4471-4475.
178. Plump A.S., Smith J.D., Hayek T., Aalto-Setala K., Walsh A., Verstuyft J.G., et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992, 71:343-353.
179. Pratico D., Tangirala R.K., Rader D.J., Rokach J., FitzGerald G.A. Vitamin E suppresses isoprostane generation in vivo and reduces atheroscle-rosis in ApoE-deficient mice. Nat Med 1998, 4:1189-1192.
180. Prescott M.F., McBride C.H., Hasler-Rapacz J., Von Linden J., Rapacz J. Development of complex atherosclerotic lesions in pigs with inher-ited hyper-LDL cholesterolemia bearing mutant alleles for apolipoprotein B. AmJPathol 1991, 139:139-147.
181. Rajewsky K., Gu H., Kuhn R., Betz U.A., Muller W, Roes J., Schwenk F. Conditional gene targeting. J Clin Invest 1996, 98:600-603.
182. Reddick R.L., Zhang S.H., Maeda N. Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arterioscler Thromb 1994, 14:141-147.
183. Reddick R.L., Zhang S.H., Maeda N. Aortic atherosclerotic plaque injury in apolipoprotein E deficient mice. Atherosclerosis 1998, 140:297-305.
184. Regan C.P., Actam P.J., Madsen C.S., Owens G.K. Molecular mecha-nisms of decreased smooth muscle differentiation marker expression after vascular injury. J. Clin Invest 2000, 106:1139-1147.
185. Reis E.D., Roque M., Cordon-Cardo C., Drobnjak M., Fuster V., Badimon J.J. Apoptosis, proliferation, and p27 expression during vessel wall healing: time course study in a mouse model of transluminal femoral artery injury. J Vase Surg 2000, 32:1022-1029.
186. Rosenfeld M.E., Polinsky P., Virmani R., Kauser K., Rubanyi G., Schwartz S.M. Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse. Arterioscler Thromb Vase Biol 2000, 20:2587-2592.
187. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999, 340:115-126.
188. Rothstein N.M., Quinn T.C., Madico G., Gaydos C., Lowenstein C.J. Effect of azithromycin on murine arteriosclerosis exacerbated by. Chlamydia pneumoniae. J Infect Dis 2001, 183:232-238.
189. Rudic R.D., Shesely E.G., Maeda N., Smithies O., Segal S.S., Sessa W.C. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest 1998, 101:731-736.
190. Salonen R.M., Nyyssonen K., Kaikkonen J., Porkkala-Sarataho E., Voutilainen S., Rissanen T.H., et al. Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation 2003, 107:947-953.
191. Sandkamp M., Funke H., Schulte H., Kohler E., Assmann G. Lipoprotein (a) is an independent risk factor for myocardial infarction at a young age. Clin Chem 1990, 36:20-23.
192. Schlager G. Spontaneous hypertension in laboratory animals: a review of the genetic implications. J. Hered 1972, 63:35-38.
193. Schober A., Knarren S., Lietz M., Lin E.A., Weber C. Crucial role of stromal cell-derived factor-1 alpha in neointima formation after vascular injury in apolipoprotein E-deficient mice. Circulation 2003, 108:2491-2497.
194. Shaish A., George J., Gilburd B., Keren P., Levkovitz H., Harats D. Dietary beta-carotene and alpha-tocopherol combination does not inhibit atherogenesis in an ApoE-deficient mouse model. Arterioscler Thromb Vase Biol 1999, 19:1470-1475.
195. Silence J., Collen D., Lijnen H.R. Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of metalloproteinase-1 (TIMP-1) gene. Cire Res 2002, 90:897-903.
196. Silence J., Lupu F., Collen D., Lijnen H.R. Persistence of atheroscle-rotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation. Arterioscler Thromb Vase Biol 2001, 21:1440-1445.
197. Singaraja R.R., Fievet C., Castro G., James E.R., Hennuyer N., Clee S.M., et al. Increased ABC Al activity protects against atherosclerosis. J Clin Invest 2002, 110:35-42.
198. Sjoland H., Eitzman D.T., Gordon D., Westrick R., Nabel E.G., Ginsburg D. Atherosclerosis progression in LDL receptor-deficient and apolipoprotein E-deficient mice is independent of genetic alterations in plasminogen activator inhibitor-1. Arterioscler Thromb Vase Biol 2000, 20:846-852.
199. Smith J.D., James D., Dansky H.M., Wittkowski K.M., Moore K.J., Breslow J.L. In silico quantitative trait locus map for atherosclerosis susceptibility in apolipoprotein E-deficient mice. Arterioscler Thromb Vase Biol 2003, 23:117-122.
200. Smith J.D., Trogan E., Ginsberg M., Grigaux C., Tian J., Miyata M. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci U S A 1995, 92:8264-8268.
201. Smithies O. Theodore Cooper Memorial Lecture: a mouse view of hypertension. Hypertension 1997, 30:1318-1324.
202. Smithies O., Maeda N. Gene targeting approaches to complex genetic diseases: atherosclerosis and essential hypertension. Proc Natl Acad Sci USA 1995, 92:5266-5272.
203. Stampfer M.J., Hennekens C.H., Manson J.E., Colditz G.A., Rosner B., Willett W.C. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993, 328:1444-1449.
204. Sukhova G.K., Zhang Y., Pan J.H., Wada Y, Yamamoto T., Naito M., et al. Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. J Clin Invest 2003, 111:897-906.
205. Sullivan P.M., Mezdour H., Aratani Y, Knouff C., Najib J., Reddick R.L., et al. Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholes-terolemia and atherosclerosis. J Biol Chem 1997, 272:17972-17980.
206. Sullivan P.M., Mezdour H., Quarfordt S.H., Maeda N. Type III hyper-lipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2. J Clin Invest 1998, 102:130-135.
207. Svenson K.L., Bogue M.A., Peters L.L. Invited review: Identifying new mouse models of cardiovascular disease: a review of high-throughput screens of mutagenized and inbred strains. JAppl Physiol 2003, 94:1650-1659.
208. Takahashi N., Smithies O. Human genetics, animal models and com-puter simulations for studying hypertension. Trends Genet 2004, 20:136-145.
209. Tangirala R.K., Casanada F., Miller E., Witztum J.L., Steinberg D., Palinski W Effect of the antioxidant N,N'-diphenyl 1,4-phenylene-diamine (DPPD) on atherosclerosis in apoE-deficient mice. Arterioscler Thromb Vase Biol 1995, 15:1625-1630.
210. Tham D.M., Martin-McNulty B., Wang Y.X., Da Cunha V., Wilson D.W., Athanassious C.N., et al. Angiotensin II injures the arterial wall causing increased aortic stiffening in apolipoprotein E-deficient mice. Am J Physiol Regul Integr Comp Physiol 2002, 283:1442-1449.
211. Thomas K.R., Capecchi M.R. Site-directed mutagenesis by gene tar-geting in mouse embryo-derived stem cells. Cell 1987, 51:503-512.
212. Thomas S.R., Leichtweis S.B., Pettersson K., Croft K.D., Mori T.A., Brown A.J., Stocker R. Dietary cosupplementation with vitamin E and coenzyme Q (10) inhibits atherosclerosis in apolipoprotein E gene knockout mice. Arterioscler Thromb Vase Biol 2001, 21:585-593.
213. Thompson J.S. Atheromata in an inbred strain of mice. J Atheroscler ito 1969, 10:113-122.
214. van den Maagdenberg A.M., Hofker M.H., Krimpenfort P.J., de Bruijn I., van Vlijmen B., van der Boom H., et al. Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia. J Biol Chem 1993, 268:10540-10545.
215. van Eck M., Bos I.S., Kaminski WE., Orso E., Rothe G., Twisk J., et al. Leukocyte ABC Al controls susceptibility to atherosclerosis and macrophage recruitment into tissues. Proc Natl Acad Sci U S A 2002, 99:6298-6303.
216. van Ree J.H., van den Broek W.J., Dahlmans V.E., Groot PH., Vidgeon-Hart M., Frants R.R., et al. Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient mice. Atherosclerosis 1994, 111:25-37.
217. van Vlijmen B.J., van den Maagdenberg A.M., Gijbels M.J., van der Boom H., HogenEsch H., Frants R.R., et al. Diet-induced hyper-lipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice. J. Clin Invest 1994, 93:1403-1410.
218. VanderLaan P.A., Reardon C.A., Getz G.S. Site specificity of athero-sclerosis: site-selective responses to atherosclerotic modulators. Arterioscler Thromb Vase Biol 2004, 24:12-22.
219. Verdant M.M., Sullivan M.A., Kim S.K., Ambroziak P., Chu A., Wilson M.D., et al. Defining the atherogenicity of large and small lipoproteins con-taining apolipoprotein B100. J. Clin Invest 2000, 106:1501-1510.
220. Virtamo J., Rapola J.M., Ripatti S., Heinonen O.P., Taylor PR., Albanes D., et al. Effect of vitamin E and beta carotene on the incidence of pri-mary nonfatal myocardial infarction and fatal coronary heart disease. Arch Intern Med 1998, 158:668-675.
221. Vliegen I., Duijvestijn A., Grauls G., Herngreen S., Bruggeman C., Stassen F. Cytomegalovirus infection aggravates atherogenesis in apoE knockout mice by both local and systemic immune activation. Microbes Infect 2004, 6:17-24.
222. Wagner J.D., Clarkson T.B., St Clair R.W., Schwenke D.C., Shively C.A., Actams M.R. Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J. Clin Invest 1991, 88:1995-2002.
223. Wang H., Jiang X., Yang F., Gaubatz J.W., Ma L., Magera M.J., et al. Hyperhomocysteinemia accelerates atherosclerosis in cystathionine beta-synthase and apolipoprotein E double knock-out mice with and without dietary perturbation. Blood 2003, 101:3901-3907.
224. Wang X., Paigen B. Comparative genetics of atherosclerosis and restenosis: exploration with mouse models. Arterioscler Thromb Vase Biol 2002, 22:884-886.
225. Warden C.H., Hedrick C.C., Qiao J.H., Castellani L.W., Lusis A.J. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Science 1993, 261:469-472.
226. Weisgraber K.H. Apolipoprotein E: structure-function relationships. Adv Protein Chem 1994, 45:249-302.
227. Weiss D., Kools J.J., Taylor W.R. Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice. Circulation 2001, 103:448-454.
228. Welch C.L., Bretschger S., Latib N., Bezouevski M., Guo Y, Pleskac N., et al. Localization of atherosclerosis susceptibility loci to chromosomes 4 and 6 using the Ldlr knockout mouse model. Proc Natl Acad Sci USA 2001, 98:7946-7951.
229. Westrick R.J., Bodary P.F., Xu Z., Shen Y.C., Broze G.J., Eitzman D.T. Deficiency of tissue factor pathway inhibitor promotes atherosclero-sis and thrombosis in mice. Circulation 2001, 103:3044-3046.
230. Whitman S.C., Ravisankar P., Daugherty A. IFN-gamma deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E-/-mice. J Interferon Cytokine Res 2002, 22:661-670.
231. Wiesmann F., Szimtenings M., Frydrychowicz A., Hunger R., Hunecke A., Rommel E., et al. High-resolution MRI with cardiac and respiratory gating allows for accurate in vivo atherosclerotic plaque visualization in the murine aortic arch. Magn Reson Med 2003, 50:69-74.
232. Williams H., Johnson J.L., Carson K.G., Jackson C.L. Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice. Arterioscler Thromb Vase Biol 2002, 22:788-792.
233. Witting P.K., Pettersson K., Letters J., Stocker R. Site-specific antiatherogenic effect of probucol in apolipoprotein E-deficient mice. Arterioscler Thromb Vase Biol 2000, 20:E26-E33.
234. Wu J.H., Hagaman J., Kim S., Reddick R.L., Maeda N. Aortic con-striction exacerbates atherosclerosis and induces cardiac dysfunction in mice lacking apolipoprotein E. Arterioscler Thromb Vase Biol 2002, 22:469-475.
235. Xiao Q., Danton M.J., Witte D.P., Kowala M.C., Valentine M.T., Bugge T.H., Degen J.L. Plasminogen deficiency accelerates vessel wall disease in mice predisposed to atherosclerosis. Proc Natl Acad Sci USA 1997, 94:10335-10340.
236. Xiao Q., Danton M.J., Witte D.P., Kowala M.C., Valentine M.T., Degen J.L. Fibrinogen deficiency is compatible with the development of athero-sclerosis in mice. J Clin Invest 1998, 101:1184-1194.
237. Yet S.F., Layne M.D., Liu X., Chen Y.H., Ith B., Sibinga N.E., Perrella M.A. Absence of heme oxygena die;se-1 exacerbates atherosclerotic lesion for-mation and vascular remodeling. FASEB 2003, J17:1759-1761.
238. Zaina S., Petterson L., Ahren B., Branen L., Hassan A.B., Lindholm M., et al. Insulin-like growth factor II plays a central role in atherosclerosis in a mouse model. J Biol Chem 2002, 277:4505-4511.
239. Zarins C.K., Giddens D.P., Bharadvaj B.K., Sottiurai VS., Mabon R.F., Glagov S. Carotid bifurcation atherosclerosis. Quantitative correla-tion of plaque localization with flow velocity profiles and wall shear stress. Cire Res 1983, 53:502-514.
240. Zhang S.H., Reddick R.L., Avdievich E., Surles L.K., Jones R.G., Reynolds J.B., et al. Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice. J Clin Invest 1997, 99:2858-2866.
241. Zhang S.H., Reddick R.L., Burkey B., Maeda N. Diet-induced ather-osclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption. J Clin Invest 1994, 94:937-945.
242. Zhang S.H., Reddick R.L., Maeda N. Studies on the pamogenesis of atherosclerosis using apolipoprotein E-deficient mice. Drugs affecting lipid metabolism 1996, 255-261. Kluwer Academic Publishers, Dordrecht, The Netherlands. A.M. Gotto, R. Paoletti, L.C. Smith, A.L. Catapano, A.S. Jackson (Eds.).
243. Zhang S.H., Reddick R.L., Piedrahita J.A., Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992, 258:468-471.